Insider Selling: Astera Labs (NASDAQ:ALAB) CEO Sells $7,173,329.94 in Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) CEO Jitendra Mohan sold 28,737 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the transaction, the chief executive officer owned 3,789,232 shares in the company, valued at approximately $945,868,091.84. The trade was a 0.75% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jitendra Mohan also recently made the following trade(s):

  • On Monday, May 18th, Jitendra Mohan sold 111,214 shares of Astera Labs stock. The stock was sold at an average price of $216.89, for a total transaction of $24,121,204.46.
  • On Monday, May 18th, Jitendra Mohan sold 95,444 shares of Astera Labs stock. The stock was sold at an average price of $225.02, for a total transaction of $21,476,808.88.
  • On Thursday, May 7th, Jitendra Mohan sold 139,951 shares of Astera Labs stock. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16.
  • On Monday, April 20th, Jitendra Mohan sold 10,188 shares of Astera Labs stock. The stock was sold at an average price of $175.45, for a total transaction of $1,787,484.60.
  • On Friday, April 17th, Jitendra Mohan sold 325,693 shares of Astera Labs stock. The stock was sold at an average price of $172.14, for a total transaction of $56,064,793.02.
  • On Wednesday, April 15th, Jitendra Mohan sold 2,967 shares of Astera Labs stock. The stock was sold at an average price of $174.60, for a total transaction of $518,038.20.
  • On Friday, April 10th, Jitendra Mohan sold 123,750 shares of Astera Labs stock. The stock was sold at an average price of $149.68, for a total transaction of $18,522,900.00.
  • On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The stock was sold at an average price of $131.58, for a total transaction of $20,723,850.00.

Astera Labs Trading Up 3.0%

Shares of Astera Labs stock opened at $306.88 on Friday. The company has a 50 day moving average of $170.39 and a 200-day moving average of $159.79. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $315.81. The company has a market cap of $52.60 billion, a PE ratio of 207.35, a price-to-earnings-growth ratio of 3.94 and a beta of 3.35.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the firm posted $0.33 EPS. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
  • Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
  • Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
  • Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

Hedge Funds Weigh In On Astera Labs

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Assetmark Inc. increased its position in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the period. Reflection Asset Management acquired a new position in Astera Labs in the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC increased its position in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the period. Hilltop National Bank increased its position in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the period. Finally, Aventura Private Wealth LLC acquired a new position in Astera Labs in the 4th quarter valued at approximately $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ALAB. Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective for the company. Royal Bank Of Canada increased their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. TD Cowen increased their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Finally, Needham & Company LLC increased their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $233.75.

Check Out Our Latest Report on Astera Labs

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.